Lemay Kate S, Saini Bandana, Bosnic-Anticevich Sinthia, Smith Lorraine, Stewart Kay, Emmerton Lynne, Burton Deborah L, Krass Ines, Armour Carol L
Woolcock Institute of Medical Research, The University of Sydney . Sydney, NSW ( Australia ).
Faculty of Pharmacy, The University of Sydney . Sydney, NSW ( Australia ).
Pharm Pract (Granada). 2015 Jan-Mar;13(1):529. doi: 10.18549/pharmpract.2015.01.529. Epub 2015 Mar 15.
Pharmacists in Australia are accessible health care professionals, and their provision of clinical pharmacy interventions in a range of areas has been proven to improve patient outcomes. Individual clinical pharmacy interventions in the area of asthma management have been very successful. An understanding of the nature of these interventions will inform future pharmacy services. What we do not know is when pharmacists provide a complex asthma service, what elements of that service (interventions) they choose to deliver.
To explore the scope and frequency of asthma-related clinical interventions provided by pharmacists to patients in an evidence-based complex asthma service.
Pharmacists from 4 states/territories of Australia were trained in asthma management. People with asthma had 3 or 4 visits to the pharmacy. Guided by a structured patient file, the pharmacist assessed the patient's asthma and management and provided interventions where and when considered appropriate, based on their clinical decision making skills. The interventions were recorded in a checklist in the patient file. They were then analysed descriptively and thematically.
Pharmacists provided 22,909 clinical pharmacy interventions over the service to 570 patients (398 of whom completed the service). The most frequently delivered interventions were in the themes 'Education on asthma', 'Addressing trigger factors', 'Medications - safe and effective use' and 'Explore patient perspectives'. The patients had a high and ongoing need for interventions. Pharmacists selected interventions based on their assessment of perceived need then revisited and reinforced these interventions.
Pharmacists identified a number of areas in which patients required interventions to assist with their asthma management. Many of these were perceived to require continuing reinforcement over the duration of the service. Pharmacists were able to use their clinical judgement to assess patients and provide clinical pharmacy interventions across a range of asthma management needs.
澳大利亚的药剂师是易于接触的医疗保健专业人员,他们在一系列领域提供临床药学干预已被证明可改善患者的治疗效果。在哮喘管理领域的个别临床药学干预非常成功。了解这些干预的性质将为未来的药学服务提供参考。我们尚不清楚的是,当药剂师提供复杂的哮喘服务时,他们会选择提供该服务(干预措施)的哪些要素。
探讨药剂师在循证复杂哮喘服务中为患者提供的与哮喘相关临床干预的范围和频率。
来自澳大利亚4个州/领地的药剂师接受了哮喘管理培训。哮喘患者到药房就诊3或4次。在结构化患者档案的指导下,药剂师评估患者的哮喘情况和管理情况,并根据其临床决策技能在认为合适的时间和地点提供干预措施。干预措施记录在患者档案的清单中。然后对其进行描述性和主题性分析。
药剂师在该服务中为570名患者提供了22,909次临床药学干预(其中398名患者完成了该服务)。最常提供的干预措施集中在“哮喘教育”、“解决触发因素”、“药物——安全有效使用”和“了解患者观点”等主题。患者对干预措施有持续的高度需求。药剂师根据对感知需求的评估选择干预措施,然后对这些干预措施进行复查和强化。
药剂师确定了患者在哮喘管理方面需要干预的一些领域。其中许多领域被认为在服务期间需要持续强化。药剂师能够运用其临床判断力评估患者,并针对一系列哮喘管理需求提供临床药学干预。